Nureca (NURECA)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 49.81% and profit growth of 233.21% show strong recent momentum
• Very low Debt/Equity of 0.03 keeps financial risk minimal
• Promoter holding at 68.09% aligns management with minority shareholders
• Piotroski F-Score of 6/9 suggests reasonably sound financial position
• P/B of 1.29 with book value of ₹207.29 means the stock is not excessively expensive on assets

Concerns

• ROE of just 4.65% and negative ROCE of -0.90% indicate weak returns on capital
• P/E of 26.47 is demanding for a business with such low current profitability
• Profit growth of 233.21% is not sustainable and makes the PEG ratio of 0.19 misleading
• No dividend yield means investors depend entirely on capital appreciation

AI Analysis

Nureca looks like a fast grower on the surface: sales up 49.81%, profits up 233.21%, and a PEG of 0.19. But I have learned to be suspicious of growth rates that are too good. A P/E of 26.47 is not extreme if growth persists, but the quality beneath the numbers worries me. The company earned only ₹4 Cr on ₹40 Cr of sales in the latest quarter, yet return on equity is just 4.65%. That means the business is not generating a high return on the shareholders' capital tied up in it. More troubling, ROCE is negative at -0.90%, so even when I ignore financing effects, the operating business is not earning a satisfactory return on capital. With book value at ₹207.29 and the price at ₹266.70, I am paying roughly a 29% premium for a business earning less than 5% on its book value. There is no dividend, so my entire expected return depends on price appreciation. The low debt-to-equity of 0.03 is a comfort, and promoter holding of 68.09% aligns their interests with mine. The Piotroski score of 6/9 is acceptable but not great. Graham would say the margin of safety is thin here. The 52-week range of ₹204 to ₹357 also reminds me that this is a volatile, relatively small stock. I would not call this a wonderful business yet. It may be an improving one, but I need to see sustained returns on capital, not just one year of explosive profit growth. Patience, not excitement, should guide a decision here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer